… (SARS-CoV and MERS-CoV), mucosal vaccination … mucosal immunity to confer protection
against SARS-CoV-2. This article summarizes the approaches to an effective mucosal vaccine …

… elicitation by parenteral versus mucosal delivery, and the challenges and opportunities
for mucosal vaccine development for SARS-CoV-2. Localised immunity at mucosal surfaces …

… new vaccine technologies to be leveraged to facilitate rational mucosal vaccine design for
… including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and for cancer. …

… During the workshop, researchers and vaccine developers from around … mucosal vaccines
to block SARS-CoV-2 transmission and reviewed the status of SARS-CoV-2 mucosal vaccine …

… inducing protective immunity against SARS outbreaks. Moreover, … Among the SARS-CoV-2
experimental vaccines, those … Thus far several vaccine candidates against SARS-CoV-2 are …

… We review here the pros and cons of each vaccination strategy, the current mucosal
SARS-CoV-2 vaccines under development, and their implications for public health. …

… This approach can be adapted for mucosal vaccines against SARS-CoV-2 utilizing a
genetic … studies are needed to develop safe and effective mucosal vaccines against SARS-CoV-2. …

… vaccines can protect against respiratory SARS-CoV-2 exposure. In summary, we have
demonstrated that the mucosal vaccine was … systemic vaccines to provide overall better protection. …

… that the developed vaccines are not effective … of SARS-CoV-2. Considering this problem, it
is promising to focus on developing a Coronavirus Disease 2019 (COVID-19) mucosal vaccine…

… -NC plus the mucosal adjuvant KFD (3Ro-NC + KFDi.n) elicits coordinated mucosal IgA and
… KFD is a promising mucosal vaccine candidate for protection against SARS-CoV-2 Omicron …